Cambridge scientists have discovered a light-powered chemical reaction that lets researchers modify complex drug molecules at the final stages of development. Unlike traditional methods that rely on ...

Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...

A surprising lab discovery reveals a light-powered way to tweak complex drugs faster, cleaner, and later in development.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including Fortrea (NASDAQ:FTRE) and ...

Detailed price information for Medpace Holdings Inc (MEDP-Q) from The Globe and Mail including charting and trades.

Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.

AISight® Dx will support fully digital workflows and AI-enabled insights across Labcorp's network of anatomic pathology labs ...

Headquartered in Northwood, Ohio, Namsa provides medical device testing, clinical research and regulatory consulting to medtech companies This acquisition is Namsa’s 10 th acquisition since becoming ...

A study published in Nature Medicine provides encouraging results for patients with diffuse pleural mesothelioma (DPM), a rare and deadly cancer often linked to asbestos exposure. Researchers ...